Publication:
Emerging role of the ubiquitin-proteasome system as drug targets

Simple item page
dc.contributor.coauthorFraternali, Franca
dc.contributor.departmentDepartment of Computer Engineering
dc.contributor.departmentDepartment of Chemical and Biological Engineering
dc.contributor.departmentCCBB (The Center for Computational Biology and Bioinformatics)
dc.contributor.facultymemberYes
dc.contributor.kuauthorGürsoy, Attila
dc.contributor.kuauthorKeskin, Özlem
dc.contributor.kuauthorMakinacı, Gözde Kar
dc.contributor.schoolcollegeinstituteCollege of Engineering
dc.contributor.schoolcollegeinstituteResearch Center
dc.date.accessioned2024-11-09T23:42:32Z
dc.date.issued2013
dc.description.abstractThe ubiquitin-proteosome system (UPS) regulates a wide range of cellular processes including protein degradation, DNA repair, transcription regulation, and cell signaling. Alterations and mutations in UPS components give rise to various human diseases, most prominently cancer and neurodegenerative disorders. Here, we review recent advances in UPS-based drug discovery highlighting the emerging relationships between the UPS and disease and discuss potential future therapeutic interventions. In particular, we focus on recent structural approaches in UPS and explain how the knowledge of protein structural details can guide the design of specifically targeted inhibitors.
dc.description.fulltextNo
dc.description.harvestedfromManual
dc.description.indexedbyWOS
dc.description.indexedbyScopus
dc.description.indexedbyPubMed
dc.description.openaccessNO
dc.description.peerreviewstatusPeer-Reviewed
dc.description.publisherscopeInternational
dc.description.readpublishN/A
dc.description.sponsoredbyTubitakEuTÜBİTAK
dc.description.sponsorshipThis work has been supported by TUBITAK (Research Grant Number: 109T343).
dc.description.studentonlypublicationNo
dc.description.studentpublicationYes
dc.description.versionN/A
dc.identifier.WoSQuartileQ2
dc.identifier.doi10.2174/1381612811319180002
dc.identifier.embargoN/A
dc.identifier.endpage3189
dc.identifier.grantno109T343
dc.identifier.issn1381-6128
dc.identifier.issue18
dc.identifier.pubmed23151131
dc.identifier.scopus2-s2.0-84878887472
dc.identifier.startpage3175
dc.identifier.urihttps://doi.org/10.2174/1381612811319180002
dc.identifier.urihttps://hdl.handle.net/20.500.14288/13340
dc.identifier.volume19
dc.identifier.wos000318156100002
dc.keywordsUbiquitin-proteosome system
dc.keywordsSisease
dc.keywordsDrug design
dc.language.isoeng
dc.publisherBentham Science Publishers
dc.relation.affiliationKoç University
dc.relation.collectionKoç University Institutional Repository
dc.relation.ispartofCurrent Pharmaceutical Design
dc.relation.openaccessN/A
dc.rightsN/A
dc.subjectPharmacology
dc.subjectPharmacy
dc.titleEmerging role of the ubiquitin-proteasome system as drug targets
dc.typeJournal Article
dspace.entity.typePublication
local.contributor.kuauthorKeskin, Özlem
local.contributor.kuauthorKar, Gözde
local.contributor.kuauthorGürsoy, Attila
relation.isGoalOfPublicationa9786601-9431-4553-9a46-013bb366fb87
relation.isGoalOfPublication.latestForDiscoverya9786601-9431-4553-9a46-013bb366fb87
relation.isOrgUnitOfPublication89352e43-bf09-4ef4-82f6-6f9d0174ebae
relation.isOrgUnitOfPublicationc747a256-6e0c-4969-b1bf-3b9f2f674289
relation.isOrgUnitOfPublicationd31df7d7-274a-4cdd-9166-96a14ab5b0a0
relation.isOrgUnitOfPublication.latestForDiscovery89352e43-bf09-4ef4-82f6-6f9d0174ebae
relation.isParentOrgUnitOfPublication8e756b23-2d4a-4ce8-b1b3-62c794a8c164
relation.isParentOrgUnitOfPublicationd437580f-9309-4ecb-864a-4af58309d287
relation.isParentOrgUnitOfPublication.latestForDiscovery8e756b23-2d4a-4ce8-b1b3-62c794a8c164

Files

Collections

Publications without Fulltext